Dirui Industrial Co., Ltd.

Dirui Industrial Co., Ltd. (hereinafter referred to as “DIRUI”, stock code: 300396), as a high-tech company held by China Resources Industrial Fund, was founded in Changchun, China in 1992. Today, DIRUI is one of the leading in vitro diagnostic companies in China held by state-owned enterprise.

Under the guidance of the company's “14th Five-Year” Plan, DIRUI has set up three major operation centers in Beijing, Wuhan and Chengdu to achieve high levels of market responsiveness and service, and two R&D centers in Changchun and Shenzhen to accelerate the product and technology output by complementing the strengths of the north and the south. With a whole industry chain of R&D, production, marketing and service of high-quality in vitro diagnostic products, DIRUI's R&D capabilities have always been at the forefront of the industry. DIRUI is one of the few companies in the industry that focuses on the development of both instruments and reagents.

DIRUI has been engaged in the IVD industry for more than 30 years with the adherence to the mission of "To Popularize Diagnostics and Benefit the Masses". By specializing in eight product lines including urinalysis, clinical chemistry, immunoassay, gynecological secretion, hematology, coagulation, molecular diagnostics, and integrated laboratory, DIRUI is able to provide comprehensive product solutions and services for medical laboratories. DIRUI’s products have gained the trust of more than 14,000 medical institutions in China and users in more than 120 countries and regions around the world. All DIRUI people will strive for “Pioneering Excellence in the IVD Industry”, shoulder the era responsibility of national diagnostic autonomy, and show the world the charm of China's smart manufacturing with excellent products.